Michael H. Davidson, CEO: NewAmsterdam Pharma NAMS Sell · Filed 02/26

Trade details

Type: Insider sale
Amount: $5,562,671.04
Shares · price: 165,408 sh · $33.63 a share
Held after: 477,783 sh
Stock: NewAmsterdam Pharma NAMS
Person: Michael H. DavidsonCEO
Trade date: 26/02/26
Filed: 26/02/26
Days to filing: 0 days

Sold 25.7% of holdings

Share of holding sold: 25.7%

NewAmsterdam Pharma trades, last 26 weeks

What else happened in NewAmsterdam Pharma around then

Filed or reported within 30 days of the trade day · 01/27~03/28

Michael H. Davidson's recent trades

Michael H. DavidsonCEO
SellNewAmsterdam Pharma
Sell
NewAmsterdam Pharma
NAMS
$14.8M
443,707 sh
$14.8M
Filed 03/02
Traded 03/02
Michael H. DavidsonAffiliate
Planned saleNewAmsterdam Pharma
Planned sale
NewAmsterdam Pharma
NAMS
$15.7M
443,707 sh
$15.7M
Filed 03/02
Traded 03/02
Michael H. DavidsonCEO
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$2.2M
61,547 sh
$2.2M
Filed 02/26
Traded 02/24
Michael H. DavidsonCEO
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$1.6M
46,517 sh
$1.6M
Filed 02/26
Traded 02/25
Michael H. DavidsonCEO
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$617.3K
17,924 sh
$617.3K
Filed 02/26
Traded 02/26

Michael H. Davidson, CEO — sold $5.6M of NewAmsterdam Pharma NAMS · 25.7% of holdings · 10b5-1 plan | Whalegun